Zimmer Biomet saw a strong first quarter, and U.S. growth in particular was bolstered by the hip franchise, CEO Ivan Tornos said in an earnings call.
“Our U.S. hip franchise grew 5% in the quarter as we are seeing increasing traction of our hip triple-play of Z1, which now represents nearly 40% of our U.S. hip stems, OrthoGrid, our AI-based hip navigation platform, and HAMMR, our surgical impactor,” Mr. Tornos said, as transcribed by Morningstar.
Part of Zimmer Biomet’s hip strategy also includes its acquisitions. Notable deals in recent years include OrthoGrid Systems and Paragon 28.
“…Our recent acquisitions are all seeing positive momentum,” Mr. Tornos said. “Paragon 28 first quarter growth accelerated around 200 basis points from the fourth quarter of 2025 and is trending back towards double-digit growth performance. OrthoGrid delivered its strongest quarter to date with significant growth and accelerated adoption, solidifying OrthoGrid as a core driver of our digital ecosystem and anterior hip triple play.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
